منابع مشابه
a study on rate making and required reserves determination in reinsurance market: a simulation
reinsurance is widely recognized as an important instrument in the capital management of an insurance company as well as its risk management tool. this thesis is intended to determine premium rates for different types of reinsurance policies. also, given the fact that the reinsurance coverage of every company depends upon its reserves, so different types of reserves and the method of their calc...
Shaping the Conversation: A Secondary Analysis of Reproductive Decision-Making Among Black Mothers with HIV.
The purpose of this qualitative secondary data analysis is to examine the major influencers on mothers with HIV in their childbearing decisions, as well as how those influencers shape conversations with clinicians and health-care providers regarding HIV treatment and prevention. The original study gained insight into the reproductive decision-making of mothers with HIV. By analyzing a subsample...
متن کاملMICHAEL JOHN BARRY, MD: a conversation with the editor on shared decision making.
M ichael Barry (Figure) was born on July 23, 1953, in Hartford, Connecticut, and grew up there. He graduated from Trinity College in 1975 and from the University of Connecticut School of Medicine in 1979. From there, he went to Strong Memorial Hospital in Rochester, New York, where he did his residency training in internal medicine. From 1983 through 1985 he was a research fellow in general int...
متن کاملA quantum conversation.
Alice: The problem with that is the scaling to problems that are nontrivially large. If the number of molecules you need is exponential in the size of a problem (as it is for searching for the bits of an entry in an unordered list, like your database), then you’re going to need an awfully big test tube to get anywhere. After all, 10 molecules used this way can solve an exponential problem for j...
متن کاملBiosimilars: Beginning a Conversation
In 2010, the Biologics Price Competition and Innovation (BPCI) Act was passed under the Patient Protection and Affordable Care Act (FDA, 2010). It created an abbreviated pathway for the approval of biologic products demonstrated to be clinically similar (or biosimilar) to or interchangeable with an approved reference product. A diverse panel of experts convened at JADPRO Live at APSHO to discus...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Creative Arts in Education and Therapy
سال: 2018
ISSN: 2451-876X
DOI: 10.15212/caet/2018/4/27